Dual nk1/nk3 antagonists for treating schizophrenia
作者： Andreas Koblet , Jens-Uwe Peters , Patrick Schnider , Andrew Sleight , Heinz Stadler
DOI:
关键词: Psychiatry 、 Schizophrenia (object-oriented programming) 、 DUAL (cognitive architecture) 、 Medicine 、 Psychotherapist
摘要: The use of compounds the general formula wherein substituents are as described in claim 1 or pharmaceutically active acid-addition salts thereof for preparation medicaments treatment schizophrenia.
lens.org参考文章(5)
Alan John Nimmo, Robert Vink, Torsten Hoffmann, Andrew Sleight, Pierre Vankan, Use of nk-1 receptor antagonists with pyridinic structure, for the treatment of brain, spinal or nerve injury ,(2002)
Christopher John Swain, Neil Roy Curtis, Brian John Williams, Jason Matthew Elliott, Janusz Jozef Kulagowski, Nadia Melanie Rupniak, Philip Stephen Jackson, Timothy Harrison, Gregory John Hollingworth, Eileen Mary Seward, Raymond Bbsrc Baker, Use of NK-1 receptors antagonists for treating schizophrenic disorders ,(1998)
Thierry Godel, Patrick Schnider, Heinz Stadler, Torsten Hoffmann, 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists ,(2001)
Thierry Godel, Walter Hunkeler, Guido Galley, Michael Montreal Boes, Patrick Schnider, Heinz Stadler, Quirico Branca, Torsten Hoffmann, 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists ,(2000)
Patrick Schnider, Andrew Sleight, Sonia Maria Poli, Torsten Hoffmann, N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives ,(2001)